In 60 years this is a first.
Shands Hospital has suspended liver and pancreas transplants because of a shortage of speciality surgeons.
The hospital de-activated the programs until they can find new surgeons. For the 125 people in Shands transplant programs, the news is unsettling, but according to the hospital it isn't dangerous.
The four people on the list who are sick enough to need transplants in the near future will be transferred to other hospitals.
Shands CEO Timothy Goldfarb says the de-activation should only last a few months. As soon as new surgeons are hired and their licenses are transferred, the programs can resume.